OLYMPUS CORP/S (OTCMKTS:OCPNY) hit a new 52-week high on Wednesday . The stock traded as high as $16.14 and last traded at $16.09, with a volume of 3341 shares traded. The stock had previously closed at $15.71.
OCPNY has been the topic of several research analyst reports. Zacks Investment Research lowered OLYMPUS CORP/S from a “buy” rating to a “hold” rating in a research report on Thursday. ValuEngine lowered OLYMPUS CORP/S from a “hold” rating to a “sell” rating in a research report on Wednesday, October 2nd.
The firm has a 50 day simple moving average of $15.25 and a two-hundred day simple moving average of $13.36. The company has a market capitalization of $21.97 billion, a PE ratio of 325.00, a P/E/G ratio of 3.52 and a beta of 0.66. The company has a current ratio of 1.23, a quick ratio of 0.80 and a debt-to-equity ratio of 0.33.
OLYMPUS CORP/S Company Profile (OTCMKTS:OCPNY)
Olympus Corporation manufactures and sells precision machineries and instruments worldwide. The company operates through four segments: Medical Business, Scientific Solutions Business, Imaging Business, and Others. It offers endoscopic video endoscopy systems, endoscopic ultrasound systems, ultrasound endoscopes and probes, endoscopic ultrasound observation devices, capsule endoscopy systems, integrated documentation systems, therapeutic equipment, and ancillary products; cleaning, disinfecting, and sterilization systems; gastrointestinal, colono, duodeno, and broncho endoscopes; endoscopy products for gastroenterological surgery, bronchial surgery, urology, gynecology, orthopedic surgery, neurosurgery, and anesthesiology, as well as ear, nose, and throat; and therapeutic and surgical equipment, endoscope ancillary equipment, and endotherapy devices.
Read More: What is a back-end load?
Receive News & Ratings for OLYMPUS CORP/S Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for OLYMPUS CORP/S and related companies with MarketBeat.com's FREE daily email newsletter.